Acne conglobata infantumL70.4

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Rare, but particularly severe form of acne infantum with nodules and abscessing fistula ducts. Endocrinological disorders frequent; clarification necessary!

LocalizationThis section has been translated automatically.

Confined to the face.

Clinical featuresThis section has been translated automatically.

papules, pustules, nodules and abscessed fistula ducts.

LaboratoryThis section has been translated automatically.

Clarification: Total and free testosterone, dehydroepiandrosterone (DHEA and DHEA-S), LH, FSH.

Differential diagnosisThis section has been translated automatically.

Complication(s)This section has been translated automatically.

Retracted fistulas.

External therapyThis section has been translated automatically.

Benzoyl peroxide (e.g. acne oxide) in lowest concentration, e.g. 1-2%, under observation for a few minutes, if necessary adapalene 0.1% (Differin gel/cream). Alternatively azelaic acid (e.g. Skinoren cream) can be tried. Deeply inflammatory efflorescences can be treated locally or intralesionally with glucocorticoids for a short time.

Internal therapyThis section has been translated automatically.

  • In the case of highly inflammatory components, antibiotics, especially erythromycin, e.g. paediathrocin 2 times/day 125 mg p.o., can be given systemically.
  • In pronounced, therapy-resistant cases, systemic treatment with isotretinoin should be considered in individual cases (0.36-1.0 mg/kg bw/day for 2-4 months). Cave! When treating with isotretinoin, no simultaneous administration of tetracyclines. Note the side effect profile of tetracyclines!

Progression/forecastThis section has been translated automatically.

Risk of considerable scarring, possibly continuation of the symptoms into adulthood.

Authors

Last updated on: 29.10.2020